Bathing with this Chinese decoction eases symptoms of sclerosis

Research has found that the Chinese decoction called Taohong Siwu can be used to treat symptoms of sclerosis. The study, published in the Chinese Journal of Integrative Medicine, assessed the efficacy and safety of bathing therapy with Taohong Siwu decoction in the treatment of diffuse cutaneous systemic sclerosis.

• Researchers from Gansu Provincial Hospital in Lanzhou, China hypothesized that adding a Chinese medicine therapy, particularly bathing with Taohong Siwu decoction, to a Western medicine therapy would improve the management of diffuse cutaneous systemic sclerosis.
• The researchers recruited 148 participants, aged 18 to 60 years, with diffuse cutaneous system sclerosis.
• They randomly divided the participants into two groups: Taohong Siwu decoction group and a placebo control group.
• The participants bathed their upper and lower limbs once a day for 12 consecutive weeks.
• Only 135 participants completed the treatment.
• There were no improvements seen in both groups after two weeks of treatment.
• At 12 weeks, the modified Rodnan skin and Raynaud’s phenomenon scores improved in the Taohong Siwu decoction group.
• Moreover, the quality of life, physician visual analog scale (VAS), patient VAS, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) level were better in the Taohong Siwu decoction group.
• Overall, patients who bathed with Taohong Siwu decoction significantly experienced greater improvements in their condition than those who received the placebo treatment.
• Taohong Siwu decoction did not cause any serious side effect.

In conclusion, the findings of the study suggested that bathing with Taohong Siwu decoction may help improve the symptoms of diffuse cutaneous systemic sclerosis.

To read more stories on Chinese medicines like Taohong Siwu, visit ChineseMedicine.news today.

Journal Reference:

Zhou J, Yang D, Zhou S. Chin J. CLINICAL EFFICACY AND SAFETY OF BATHING WITH CHINESE MEDICINE TAOHONG SIWU DECOCTION (?????) FOR TREATMENT OF DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: A RANDOMIZED PLACEBO-CONTROLLED TRIAL. Chinese Journal of Integrative Medicine. March 2018; 24(3): 185-192. DOI: 10.1007/s11655-017-2954-2